Objective To investigate the predictive value of serum forkhead box protein O3(FOXO3)and thioredoxin interacting protein(TXNIP)for major adverse cardiovascular event(MACE)in elderly patients with coronary heart disease(CHD)following percutaneous coronary intervention(PCI).Methods In total,120 elderly patients with CHD who underwent successful PCI at our hospital between June 2021 and May 2023 were enrolled.After 12 months of follow-up(6 patients lost to follow-up),the patients were divided into the MACE group(n=40)and non-MACE group(n=74)based on whether they experienced MACE,such as recurrent angina pectoris,acute myocardial infarction,and severe arrhythmia.Enzyme-linked immunosorbent assay was used to detect FOXO3 and TXNIP levels in serum.The Pearson analysis was used to analyze the correlation between serum FOXO3 and TXNIP levels in patients with CHD.A receiver operating characteristic(ROC)curve was applied to analyze the predictive value of serum FOXO3 and TXNIP levels for MACE in patients with CHD after PCI.Logistic regression was used to analyze the factors affecting the occurrence of MACE in patients with CHD after PCI.Results The serum FOXO3 level in the MACE group was significantly lower than that in the non-MACE group,while TXNIP levels were significantly higher(P＜0.05).Pearson analysis revealed that serum FOXO3 and TXNIP levels in patients with CHD were negatively cor-related(r=-0.586,P＜0.001).Logistic regression analysis revealed that FOXO3 and TXNIP were factors influencing MACE in patients with CHD after PCI(P＜0.05).The combined prediction of serum FOXO3 and TXNIP for MACE in patients with CHD after PCI had higher area under the curve than using FOXO3 and TXNIP alone(Z=7.583,P＜0.001;Z=8.640,P＜0.001).Conclusion The elderly CHD patients with MACE after PCI showed low FOXO3 expression and high TXNIP expression,which have a clinical predictive value for MACE occurrence in patients with CHD after PCI.

Objective To investigate the predictive value of serum forkhead box protein O3(FOXO3)and thioredoxin interacting protein(TXNIP)for major adverse cardiovascular event(MACE)in elderly patients with coronary heart disease(CHD)following percutaneous coronary intervention(PCI).Methods In total,120 elderly patients with CHD who underwent successful PCI at our hospital between June 2021 and May 2023 were enrolled.After 12 months of follow-up(6 patients lost to follow-up),the patients were divided into the MACE group(n=40)and non-MACE group(n=74)based on whether they experienced MACE,such as recurrent angina pectoris,acute myocardial infarction,and severe arrhythmia.Enzyme-linked immunosorbent assay was used to detect FOXO3 and TXNIP levels in serum.The Pearson analysis was used to analyze the correlation between serum FOXO3 and TXNIP levels in patients with CHD.A receiver operating characteristic(ROC)curve was applied to analyze the predictive value of serum FOXO3 and TXNIP levels for MACE in patients with CHD after PCI.Logistic regression was used to analyze the factors affecting the occurrence of MACE in patients with CHD after PCI.Results The serum FOXO3 level in the MACE group was significantly lower than that in the non-MACE group,while TXNIP levels were significantly higher(P＜0.05).Pearson analysis revealed that serum FOXO3 and TXNIP levels in patients with CHD were negatively cor-related(r=-0.586,P＜0.001).Logistic regression analysis revealed that FOXO3 and TXNIP were factors influencing MACE in patients with CHD after PCI(P＜0.05).The combined prediction of serum FOXO3 and TXNIP for MACE in patients with CHD after PCI had higher area under the curve than using FOXO3 and TXNIP alone(Z=7.583,P＜0.001;Z=8.640,P＜0.001).Conclusion The elderly CHD patients with MACE after PCI showed low FOXO3 expression and high TXNIP expression,which have a clinical predictive value for MACE occurrence in patients with CHD after PCI.

Objective To explore the optimized ratio of magnesium sulfate and compound polyethylene glycol electric dissolution of two common colon cleansing agent in the preparation of intestinal microscopy, so as to provide references for bowel preparation in clinical colonoscopy treatment. Methods A total of 480 cases of outpatients and inpatients for colonoscopy from March 2016 to March 2017 were selected. All the patients who took magnesium sulfate and compound polyethylene glycol electric dissolution were respectively assigned into four groups according to the dosage and different time of administration, with 60 cases in each group. The effects of bowel preparation and the incidence of adverse effects were compared. Results In the magnesium sulfate groups, there were 53 cases of ClassⅠthe score of bowel cleaning in the group of taking 25% magnesium sulfate 100 ml and water 2 000 ml orally in 1 hour, which was better than the other 3 groups. Hintergroup was 105.654 1 (P<0.01), and Hinterclass was 124.259 9 (P<0.01), and the differences was statistically significant. In the compound polyethylene glycol electric dissolution groups, there were 51 cases of ClassⅠthe score of bowel cleaning in the group of taking 2 boxes of compound polyethylene glycol electric dissolution with water 1 500 ml in 0.5 hour, which was better than the other 3 groups. Hintergrop was 79.280 3, and Hinterclass was 145.504 2, and the difference was statistically significant (P<0.01). There was no statistical significance in the differences of the incidence of adverse effects (H=47.25, 19.50;P>0.05). Conclusions When using magnesium sulfate in the colonoscopy bowel preparation, taking 25% magnesium sulfate 100 ml and warm water 2 000 ml in 1 hour by oral could get the best colon cleaning effects. When using compound polyethylene glycol electric dissolution, the best cleaning effect ratio is 2 boxes of compound polyethylene glycol electric dissolution with water 1 500 ml in 1 hour, which is suitable for popularization and application.

BACKGROUND:It is not fuly understood that whetherp53 inhibitor can directly intervene in the viability of bone marrow mesenchymal stem cels and the possible mechanism. OBJECTIVE:To investigate the effect of p53 inhibitor, PFT-α, on the aging process of bone marrow mesenchymal stem cels in late-phase amplification and to discover the key target to delay the replicative senescence of human bone marrow mesenchymal stem cels. METHODS:The expression levels ofp53,p21, andp15 mRNA in human bone marrow mesenchymal stem cels in both early and late-phase amplification were detected by quantitative PCR assay. Then, human bone marrow mesenchymal stem cels in late-phase amplification were respectively treated with 20 μmol/L PFT-α or an equivalent amount of dimethyl sulfoxide for 2 weeks. The positive rate of aging cels was determined by SA-β-Gal staining. The apoptosis was detected by TUNEL staining. Human bone marrow mesenchymal stem cels were treated with 300 μmol/L H2O2 for 30 minutes, and then celular anti-oxidative stress capacity was detected by cel counting kit-8 assay. RESULTS AND CONCLUSION:The quantitative PCR assay showed that the mRNA expression level ofp15, p21 andp53 in human bone marrow mesenchymal stem cels in late-phase amplification was significantly increased (1.45±0.23), (1.51±0.14) and (1.78±0.14) times as much as that in early phase amplification (P < 0.05). The positive rate of aging cels in PFT-α group was significantly lower than that in the dimethyl sulfoxide group[(41±5)%vs. (63±7)%,P < 0.05)]. However, there was no significant difference in apoptosis rate between PFT-α group and dimethyl sulfoxide group. After treatment with H2O2, the absorbance value in the PFT-α group was(1.27±0.13) times as much as that in the dimethyl sulfoxide group (P < 0.001). The above results demonstrate that the activation ofp53 signaling pathway may be an important factor of causing aging of human bone marrow mesenchymal stem cels. Application ofp53 inhibitor PFT-αcan enhance the anti-oxidative stress capacity of human bone marrow mesenchymal stem cels in late phrase amplification.

BACKGROUND:Cationic liposome-mediated celltransfection is reliable and repeatable. However the transfection efficiency is often low.
OBJECTIVE:To study the optimized methods for gene transfection mediated by liposome into N2a cells (mouse neuroblastma cells).
METHODS:Using traditional adherent method and improved suspension method, 500 ng recombinant plasmid pcDNA3-GFP carrying green fluorescence protein was transfected into N2a cells in 24-wel culture plate, which was mediated by 1.5μL Lipofectamine?LTX Reagent. The expression of green fluorescent protein was observed by inverted fluorescence microscope, and the transfection efficiencies at different transfection ways were calculated. By using improved suspension transfection method, 500 ng plasmid DNA was transfected with different doses of Lipofectamine?LTX Reagent (1.0, 1.5, 2.0, 2.5μL). The optimal ratio of liposome and DNA was explored.
RESULTS AND CONCLUSION:The transfection efficiency of suspension transfection method was significantly higher than that of the tranditional adherent method (P<0.01) when using 1.5μL liposome/500 ng DNA. The transfection efficiency of the 1.0, 1.5, 2.0, 2.5μL Lipofectamine?LTX on 500 ng plasmid DNA was respectively (76.60±3.85)%, (80.00±4.17)%, (88.00±5.89)%, (54.96±4.23)%. It showed the 500 ng DNA and 2.0μL liposome achieve the highest transfection efficiency.

AIM: To investigate the process of human bone marrow stromal cells (hBMSCs) differentiation into neural-like cells and to determine the role of 26S proteasome in neuronal differentiation. METHODS: Purified hBMSCs were treated with β-mercaptoethanol (β-ME) for 1 day and retinoic acid (RA) for 3 days, followed by growth factor (10 μg/L bFGF or 20 μg/L NGF) for another 3 days. Immunofluorescence was performed to detect the expression of nestin (a neural precursor cells marker), Tuj1 (a premature neuronal marker), and neurofilament (NF, a mature neuronal marker) at all stages of induced differentiation. Immunostaining and RT-PCR were used to analyze the expression of 26S proteasome during neuronal differentiation of hBMSCs. To further confirm the role of 26S proteasome in hBMSCs differentiation, cells were treated with β-ME/RA and then followed by protesome inhibitor MG132 and growth factor. Immunostaining was performed to detect NF-positive cells. RESULTS: Quantification results showed that the untreated cells were almost never positive for nestin, Tuj1 and NF. After treated with β-ME/RA, the numbers of nestin-positive cells (34.41%±1.27%) and Tuj1-positive cells (27.79%±1.27%) were increased. Notably, the numbers of NF-positive cells were significantly increased to 56.72%±2.4% after induction with β-ME/RA/GF. Immunofluorescence analysis showed that undifferentiated hBMSCs cells were weakly stained by antibody against 26S proteasome, but the numbers of cells with high-intensity of 26S proteasome were increased after treated with β-ME/RA. The RT-PCR result of 26S proteasome further confirmed that the mRNA level of the cells differentiated by β-ME/RA (1.33), as well as by β-ME/RA/GF (1.77), was significantly increased compared to the undifferentiated cells. Moreover, hBMSCs incubated with protesome inhibitor MG132 significantly decreased the numbers of NF-positive cells (37.59%±1.52%). CONCLUSION: After induction with β-ME/RA/GF, hBMSCs can be differentiated into neural-like cells, which is concomitant with the increase in 26S proteasome expression. Inhibitor of 26S protesome prevents hBMSCs differentiation, suggesting that 26S proteasome may be involved in the differentiation of hBMSCs into neural-like cells.

The article discussed the necessity of strengthening continuous medical education in general hospitals,and puts forward that to establish high quality medical staff that can keep up with time,take the challenges and promote the innovation and the development of hospital,We must attach importance to strengthening and continuing medical education,and at the same time,improving and perfecting the education system is also very important.